Increase (Decrease) in Accounts Receivable of CITIUS ONCOLOGY, INC. for 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
- Summary
-
CITIUS ONCOLOGY, INC. quarterly Increase (Decrease) in Accounts Receivable in USD history and change rate for 31 Dec 2025.
- CITIUS ONCOLOGY, INC. Increase (Decrease) in Accounts Receivable for the quarter ending 31 Dec 2025 was $4,049,111.
- Source SEC data
- View on sec.gov
Increase (Decrease) in Accounts Receivable, Quarterly (USD)
CITIUS ONCOLOGY, INC. Quarterly Increase (Decrease) in Accounts Receivable (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $4,049,111 | 01 Oct 2025 | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.